CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice
Male
0301 basic medicine
Protein Conformation
Science
Dopamine
Prefrontal Cortex
Synaptic Transmission
Article
Mice
03 medical and health sciences
Antigens, CD
Animals
Humans
Child
Neurons
0303 health sciences
Gene Expression Profiling
Siblings
Q
Homozygote
Cadherins
3. Good health
Attention Deficit Disorder with Hyperactivity
Mutation
Methylphenidate
Synaptic Vesicles
Locomotion
DOI:
10.1038/s41467-021-26426-1
Publication Date:
2021-10-26T10:03:16Z
AUTHORS (17)
ABSTRACT
AbstractAttention-deficit hyperactivity disorder (ADHD) is a common childhood-onset psychiatric disorder characterized by inattention, impulsivity and hyperactivity. ADHD exhibits substantial heritability, with rare monogenic variants contributing to its pathogenesis. Here we demonstrate familial ADHD caused by a missense mutation in CDH2, which encodes the adhesion protein N-cadherin, known to play a significant role in synaptogenesis; the mutation affects maturation of the protein. In line with the human phenotype, CRISPR/Cas9-mutated knock-in mice harboring the human mutation in the mouse ortholog recapitulated core behavioral features of hyperactivity. Symptoms were modified by methylphenidate, the most commonly prescribed therapeutic for ADHD. The mutated mice exhibited impaired presynaptic vesicle clustering, attenuated evoked transmitter release and decreased spontaneous release. Specific downstream molecular pathways were affected in both the ventral midbrain and prefrontal cortex, with reduced tyrosine hydroxylase expression and dopamine levels. We thus delineate roles for CDH2-related pathways in the pathophysiology of ADHD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (90)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....